SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

DCM Shriram rises on commissioning Epichlorohydrin plant in Gujarat

15 Oct 2025 Evaluate

DCM Shriram is currently trading at Rs. 1169.35, up by 2.55 points or 0.22% from its previous closing of Rs. 1166.80 on the BSE.

The scrip opened at Rs. 1174.00 and has touched a high and low of Rs. 1180.00 and Rs. 1165.35 respectively. So far 1047 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1501.70 on 24-Jul-2025 and a 52 week low of Rs. 904.55 on 04-Mar-2025.

Last one week high and low of the scrip stood at Rs. 1203.80 and Rs. 1157.05 respectively. The current market cap of the company is Rs. 18172.74 crore.

The promoters holding in the company stood at 66.52%, while Institutions and Non-Institutions held 12.20% and 21.27% respectively.

DCM Shriram has commissioned its Epichlorohydrin (ECH) plant of 35,000 TPA at its Chemical complex in Jhagadia, Bharuch Dist., Gujarat on October 14, 2025. The balance capacity of 17,000 TPA will be commissioned shortly.

ECH serves as an all-important link between the existing Chlor-alkali business vertical and the vertical of ‘advanced materials’, as on one side ECH is a chlorine-downstream product and on the other, ECH is a key raw material for producing ‘liquid epoxy resins’.

DCM Shriram runs two businesses energy intensive and agri business. The company is also the third largest manufacturer of Chlor-Alkali in the India. They have launched value added UPVC window system business under the Fenesta TM brand in India.

DCM Shriram Share Price

1225.85 40.85 (3.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2718.25
DCM Shriram 1225.85
3M India 31394.15
Hindustan Foods 509.15
Balmer Lawrie & Co 176.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×